The Valley Desk

Clinical trial reportAmerican journal of hematologyPublished

Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort

12 of 39 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
American journal of hematology
Published
Subject terms
Humans; Graft vs Host Disease; Cyclophosphamide; Immunosuppressive Agents; HLA Antigens; Transplantation Conditioning; Hematopoietic Stem Cell Transplantation; Transplantation, Homologous; Prospective Studies; Adult; Aged; Middle Aged
PubMed ID
42674730
PubMed Central ID
PMC13656881
Added to directory
Source checked

Report a correction or request removal